This seminar is the second in the SHAAP/ SARN 2025 Alcohol Occasional series and will take place on Monday 23rd June (12.45-2pm).
The SHAAP/ SARN Alcohol Occasionals showcase new and innovative research on alcohol. These free online events provide the chance for researchers, healthcare professionals, policy makers, and members of the public to hear about alcohol-related topics and to discuss and debate the implications for policy and practice.Â
To register, please visit the seminar’s Eventbrite page: https://www.eventbrite.co.uk/e/alcohol-occasional-2-relapse-prevention-and-alcohol-related-cirrhosis-tickets-1280583723389
Seminar background
Alcohol specific deaths are an at all-time high in the UK and 80% of these deaths are due to alcohol related liver disease (ArLD). For patients admitted to hospital with advanced ArLD, abstinence after discharge is the key determinant of outcome. However, few patients access relapse prevention support and relapse rates are high. There are likely to be some challenges which are unique to patients with advanced liver disease.
The objective of this study was to understand the barriers and facilitators of abstinence in this setting. We conducted an online survey of experts and stakeholders involved in the care of patients with ArLD. The survey was disseminated through social media posts and direct e-mail invitations. Free text answers were provided to open questions. Answers were analysed thematically on Nvivo.
Speaker bio
Dr Christopher Oldroyd is a Hepatology registrar at the Cambridge Liver Unit. He was awarded an NIHR Doctoral Fellowship and is in the final year of his PhD which looks at optimising relapse prevention in patients with alcohol related cirrhosis.
